Article
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells.
Scientific reports - 14 Jul 2017
Dabiri Yasamin, Kalman Sara, Gürth Clara-Marie, Kim Jee Young, Mayer Viola, Cheng Xinlai
Abstract excerpt
Mutations in the tumor suppressor p53 are among the most highly occurring events in colorectal cancer (CRC). Such mutations have been shown to influence the sensitivity of cancer cells to chemotherapeutic agents. However their impact on the efficacy of the proteasomal inhibitor bortezomib remains controversial. We thus re-evaluated the toxicity of bortezomib in the CRC cell lines HCT116 wt (wild-type) and its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
